Valuation
52-Week Range
0.06 - 0.98
Annual income statement
#
Valerio Therapeutics annual revenue, operating income and net income in EUR, 2016 to 2025. Revenue was 2.6m in 2025.
| Year |
Revenue (EUR) |
Operating income |
Net income |
Net margin |
| 2025 |
2.6m |
-550,000 |
-4.9m |
|
| 2024 |
1.8m |
-16.5m |
-23.9m |
|
| 2023 |
1.8m |
-20.3m |
-20.3m |
|
| 2022 |
1.4m |
-17.1m |
-19.6m |
|
| 2021 |
4.1m |
-7.3m |
-5.9m |
|
| 2020 |
1.8m |
-8.9m |
1.1m |
61.3% |
| 2019 |
4.3m |
-9.8m |
-33.7m |
|
| 2018 |
6.1m |
-15.6m |
-9.4m |
|
| 2017 |
9.5m |
-19.2m |
-59.1m |
|
| 2016 |
4.4m |
-23.2m |
-22.7m |
|
| Date |
Type |
Details |
Price |
Amount |
|